A Protocol to Streamline Dental Care in Autistic Children (DentAutism)

September 23, 2022 updated by: MUCIGNAT CARLA, University of Padova

A Three-years Project for Assistance and Dental Care of Children With Autistic Spectrum Disorder at the Community Dentistry Unit - Piove di Sacco Hospital (Padua, Italy)

The investigators aim at creating a dedicated pathway to allow accessibility to dental care for ASD children within a hospital Dentistry Department, in order to diminish the need for general anesthesia. Visual pedagogy, parent training, a strict schedule for appointments (every two months) spanning over three years and longer duration of dedicated examination are set up for a group of ASD children, whose behavior is compared to that of children seen one or twice a year.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Treated group:

Enrollment: caregivers receive instructions and a visual pedagogy aid with instructions for toothbrushing. They complete also enrollment and informed consent forms.

At the first visit: caregivers receive a dental mirror to be used at home. Children are free to explore the office and dental room.

Subsequent visits, every two months for three years: trials are made to establish contact with children, make them seat at the dentist's chair, execute dental visits and treatments as needed.

Control group: subjects (similar inclusion and exclusion criteria) that access the Department for clinical reasons or control visits, but cannot comply with the strict two-months schedule.

Study Type

Interventional

Enrollment (Actual)

170

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • PD
      • Piove Di Sacco, PD, Italy, 35028
        • Piove di Sacco Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 13 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age: 4 to 13 years old at the beginning of the treatment,
  • Diagnosis: formally diagnosed by a Neuro-psychiatrist and recognized by authorities (for school support) as having Autistic Spectrum Disorder (ASD), possibly also in the frame of genetic syndromes, or Pervasive Developmental Disorder-Not Otherwise Specified (PDD-NOS), a diagnosis present in DSM 4 and merged to ASD in DSM 5.

Exclusion Criteria:

  • Age outside the selected range
  • additional diseases, preventing autonomous oral hygiene (e.g., motor diseases),
  • for the Treated Group: familiarity with dental treatments (possible one or few visits in the past, but not on a regular base)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Behavioral support
Usual clinical intervention and in addition: visual pedagogy, instruction of caregivers, a visit every two months for three years, fixed duration of the visit (one hour) regardless of patients' collaboration. General anesthesia if needed.
Behavioral support as described under 'Arm description'.
No Intervention: Control No behavioral support
Usual clinical treatment (dentist visit and treatments). No visual pedagogy and instruction of caregivers. Twice a year schedule (more if needed), duration of the visits according to compliance. General anesthesia if needed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Collaboration
Time Frame: Change in degree of collaboration from baseline at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36 months.
Degree of collaboration on Frankl's scale, from 0 (none) to 3 (optimal)
Change in degree of collaboration from baseline at 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptance
Time Frame: Year 1, month 2
Acceptance of every action or instrument: Yes/No
Year 1, month 2
Acceptance
Time Frame: Year 1, month 4
Acceptance of every action or instrument: Yes/No
Year 1, month 4
Acceptance
Time Frame: Year 1, month 6
Acceptance of every action or instrument: Yes/No
Year 1, month 6
Acceptance
Time Frame: Year 1, month 8
Acceptance of every action or instrument: Yes/No
Year 1, month 8
Acceptance
Time Frame: Year 1, month 10
Acceptance of every action or instrument: Yes/No
Year 1, month 10
Acceptance
Time Frame: Year 1, month 12
Acceptance of every action or instrument: Yes/No
Year 1, month 12
Acceptance
Time Frame: Year 2, month 2
Acceptance of every action or instrument: Yes/No
Year 2, month 2
Acceptance
Time Frame: Year 2, month 4
Acceptance of every action or instrument: Yes/No
Year 2, month 4
Acceptance
Time Frame: Year 2, month 6
Acceptance of every action or instrument: Yes/No
Year 2, month 6
Acceptance
Time Frame: Year 2, month 8
Acceptance of every action or instrument: Yes/No
Year 2, month 8
Acceptance
Time Frame: Year 2, month 10
Acceptance of every action or instrument: Yes/No
Year 2, month 10
Acceptance
Time Frame: Year 2, month 12
Acceptance of every action or instrument: Yes/No
Year 2, month 12
Acceptance
Time Frame: Year 3, month 2
Acceptance of every action or instrument: Yes/No
Year 3, month 2
Acceptance
Time Frame: Year 3, month 4
Acceptance of every action or instrument: Yes/No
Year 3, month 4
Acceptance
Time Frame: Year 3, month 6
Acceptance of every action or instrument: Yes/No
Year 3, month 6
Acceptance
Time Frame: Year 3, month 8
Acceptance of every action or instrument: Yes/No
Year 3, month 8
Acceptance
Time Frame: Year 3, month 10
Acceptance of every action or instrument: Yes/No
Year 3, month 10
Acceptance
Time Frame: Year 3, month 12
Acceptance of every action or instrument: Yes/No
Year 3, month 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Carla Mucignat, Ph.D., University of Padova

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Actual)

December 31, 2021

Study Completion (Actual)

December 31, 2021

Study Registration Dates

First Submitted

September 14, 2022

First Submitted That Met QC Criteria

September 20, 2022

First Posted (Actual)

September 23, 2022

Study Record Updates

Last Update Posted (Actual)

September 27, 2022

Last Update Submitted That Met QC Criteria

September 23, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Only anonymized data, including age, sex, diagnosis and the collected measurements, will be made available to other researchers. Individual Participant data that allow identification of the single participant cannot be shared, as requested by the Ethical Committee.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on Behavioral support

Subscribe